Results 21 to 30 of about 32,270 (211)

An epidemiological surveillance study (2021–2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China

open access: yesBMC Infectious Diseases, 2023
Background Clostridioides difficile is a bacterium that causes antibiotic-associated infectious diarrhea and pseudomembranous enterocolitis. The impact of C. difficile infection (CDI) in China has gained significant attention in recent years.
Yihong Cui   +12 more
doaj   +1 more source

Fecal Transplantation for —“All Stool May Not Be Created Equal”

open access: yesJournal of the International Association of Providers of AIDS Care, 2016
Clostridium difficile is a gram-positive bacterium that is recognized as a causative organism of pseudomembranous enterocolitis. This infection has become a major public health challenge and is a source of considerable morbidity and mortality in those ...
Joseph C. Gathe MD, FACP, FIDSA   +3 more
doaj   +1 more source

Faecal microbiota transplantation : a regulatory hurdle? [PDF]

open access: yes, 2017
During faecal microbiota transplantation, stool from a healthy donor is transplanted to treat a variety of dysbiosis-associated gut diseases. Competent authorities are faced with the challenge to provide adequate regulation.
De Spiegeleer, Bart   +3 more
core   +2 more sources

Hospitalizations and Deaths Associated with Clostridium difficile Infection, Finland, 1996–2004

open access: yesEmerging Infectious Diseases, 2009
To determine whether the rate of Clostridium difficile–associated disease (CDAD) and CDAD-related deaths were increasing in Finland, we analyzed registry data from 1996 through 2004.
Outi Lyytikäinen   +6 more
doaj   +1 more source

Fecal microbiota transplants: Emerging social representations in the English-language print media [PDF]

open access: yes, 2019
open access articleThis study investigates how English-language news sources have represented fecal microbiota transplants (FMT). FMT involves transferring stool from a healthy donor to a recipient with a dysfunctional intestinal flora in order to ...
Jaspal, Rusi   +2 more
core   +4 more sources

Clostridium difficile infection

open access: yesAutopsy and Case Reports, 2014
Clostridium difficile infection (CDI) is a significant and increasing medical problem, surpassing methicillin-resistant Staphylococcus aureus as the most common hospital-onset or facility-associated infection, and a key element in the challenging battle ...
Stephen A. Geller   +1 more
doaj   +1 more source

Pseudomembranous enterocolitis cured with three intestinal microbiota transplantations

open access: yes, 2018
We present a unique case of a 82 years old women, with this newly described condition called “pseudomembranous enterocolitis cured with three transplants of intestinal microbi0ta (imt).” We evaluated the case of gaw, who had a perforates sigmoid ...
Álvaro Zamudio-Tiburcio   +4 more
semanticscholar   +1 more source

Faecal Microbiota Transplantation plus selected use of antibiotics for severe-complicated Clostridium difficile infection: description of a protocol with high success rate [PDF]

open access: yes, 2015
Background Severe and severe/complicated Clostridium difficile infection (CDI) can result in ICU admission, sepsis, toxic megacolon and death. In this setting, colectomy is the standard of care but it is associated with a 50% mortality.
Cook, Gwen K.   +6 more
core   +1 more source

Diarrhoea caused by Clostridium difficile in patients with postoperative subhepatic abscess [PDF]

open access: yes, 2008
Background. Toxigenic strains of Clostridium difficile in the majority of cases cause disease of the intestinal tract of hospitalized patients. For a long time, Clostridium difficile was considered to produce both types of toxins (A+/B+ strain), however,
Kocić Branislava, Stojanović Predrag
core   +1 more source

Clostridium difficile outbreaks: Prevention and treatment strategies [PDF]

open access: yes, 2012
The incidence and severity of Clostridium difficile infection (CDI) have increased dramatically over the past decade. Its treatment, however, has largely remained the same with the exception of oral vancomycin use as a first-line agent in severe disease.
Kelly, Ciaran Patrick   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy